Mitochondria-Targeted Therapies Show Promise for Acute Pancreatitis

Authors
Journal
Digestive Diseases and Sciences
Year
DOI
10.1007/s10620-026-09806-9
Study Type
clinical
Peer Reviewed
Yes
Country
Ukraine
Health Condition
Acute Pancreatitis
Body System
Digestive System

TL;DR

Scientists found that targeting the "power plants" inside pancreas cells (called mitochondria) could be a promising new way to treat severe pancreatic inflammation, because these damaged power plants are a big part of what makes pancreatitis so harmful. The catch is that while this approach works really well in lab tests and animal studies, doctors haven't yet proven it works in real patients, so more testing is needed before it can become an actual treatment.

Key Finding

Multiple mitochondria-targeted compounds reduced pancreatic injury in laboratory and animal models of acute pancreatitis, but clinical evidence in humans remains limited.

Summary

This review examined research on how targeting mitochondria (the energy-producing structures in cells) might help treat acute pancreatitis, a serious inflammation of the pancreas. Researchers looked at dozens of studies testing various compounds—including hydrogen-rich saline, coenzyme Q10, melatonin, and others—that aim to restore mitochondrial function and reduce pancreatic damage. Most evidence comes from laboratory and animal studies showing these approaches can work, but very few human trials have been conducted yet.

Practical Takeaway

While this review identifies hydrogen-rich saline and other mitochondrial-support compounds as promising in early research, the evidence is almost entirely from animal studies and lab work—not human trials. Anyone interested in these approaches should know that translation to actual clinical benefit in patients has not yet been established, and more rigorous human studies are needed before any health claims can be made.

Abstract (excerpt)

Purpose: To synthesize experimental and clinical evidence on mitochondria-targeted strategies in acute pancreatitis (AP) and evaluate the potential of interventions that preserve or restore mitochondrial function to reduce pancreatic injury and systemic complications. Methods: We conducted…

Read the full abstract via DOI